abstract |
The present invention relates to compounds of formula (I) wherein the substituents, including their pharmaceutical compositions, are as defined in the above claims and are useful for the treatment and / or prevention of one or more diseases or disorders associated with FXR activity, 0.0 > (I) < / RTI > The present invention also relates to intermediates and processes for the preparation of compounds of formula (I) |